ClinicalTrials.gov record
Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone
ClinicalTrials.gov ID: NCT00968968
Public ClinicalTrials.gov record NCT00968968. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
ClinicalTrials.gov public records Last synced Apr 29, 2026, 8:32 AM EDT
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Phase III, Open-label Study of Lapatinib Plus Trastuzumab Versus Trastuzumab as Continued HER2 Suppression Therapy After Completion of First- or Second-line Trastuzumab Plus Chemotherapy in Subjects With HER2-positive Metastatic Breast Cancer
Study identification
- NCT ID
- NCT00968968
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Enrollment
- 37 participants
Conditions and interventions
Conditions
Interventions
- Lapatinib Drug
- Trastuzumab Biological
Drug · Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 19, 2010
- Primary completion
- Feb 20, 2014
- Completion
- Mar 29, 2018
- Last update posted
- Jun 9, 2019
2010 – 2018
United States locations
- U.S. sites
- 112
- U.S. states
- 19
- U.S. cities
- 96
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novartis Investigative Site | Chandler | Arizona | 85224 | — |
| Novartis Investigative Site | Flagstaff | Arizona | 86001 | — |
| Novartis Investigative Site | Gilbert | Arizona | 85297 | — |
| Novartis Investigative Site | Mesa | Arizona | 85202 | — |
| Novartis Investigative Site | Mesa | Arizona | 85206 | — |
| Novartis Investigative Site | Sedona | Arizona | 86336 | — |
| Novartis Investigative Site | Tucson | Arizona | 85724 | — |
| Novartis Investigative Site | Bakersfield | California | 93309 | — |
| Novartis Investigative Site | Beverly Hills | California | 90211 | — |
| Novartis Investigative Site | Fullerton | California | 92835 | — |
| Novartis Investigative Site | La Jolla | California | 92037 | — |
| Novartis Investigative Site | La Jolla | California | 92093-0987 | — |
| Novartis Investigative Site | Long Beach | California | 90813 | — |
| Novartis Investigative Site | Los Angeles | California | 90095- 7187 | — |
| Novartis Investigative Site | San Diego | California | 92103-8411 | — |
| Novartis Investigative Site | San Pablo | California | 94806 | — |
| Novartis Investigative Site | Santa Maria | California | 93454 | — |
| Novartis Investigative Site | Hollywood | Florida | 33021 | — |
| Novartis Investigative Site | Hudson | Florida | 34667 | — |
| Novartis Investigative Site | New Port Richey | Florida | 34655 | — |
| Novartis Investigative Site | Augusta | Georgia | 30901 | — |
| Novartis Investigative Site | Augusta | Georgia | 30909 | — |
| Novartis Investigative Site | Dublin | Georgia | 31021 | — |
| Novartis Investigative Site | Arlington Heights | Illinois | 60005 | — |
| Novartis Investigative Site | Chicago | Illinois | 60611 | — |
| Novartis Investigative Site | Evanston | Illinois | 60201 | — |
| Novartis Investigative Site | Glenview | Illinois | 60025 | — |
| Novartis Investigative Site | Highland Park | Illinois | 60035 | — |
| Novartis Investigative Site | Joliet | Illinois | 60435 | — |
| Novartis Investigative Site | Niles | Illinois | 60714 | — |
| Novartis Investigative Site | Peoria | Illinois | 61615 | — |
| Novartis Investigative Site | Peoria | Illinois | 61636 | — |
| Novartis Investigative Site | Peoria | Illinois | 61637 | — |
| Novartis Investigative Site | Skokie | Illinois | 60076 | — |
| Novartis Investigative Site | Winfield | Illinois | 60190 | — |
| Novartis Investigative Site | Goshen | Indiana | 46526 | — |
| Novartis Investigative Site | Mishawaka | Indiana | 46545 | — |
| Novartis Investigative Site | Columbia | Maryland | 21044 | — |
| Novartis Investigative Site | Silver Spring | Maryland | 20910 | — |
| Novartis Investigative Site | Boston | Massachusetts | 02114 | — |
| Novartis Investigative Site | Boston | Massachusetts | 02215 | — |
| Novartis Investigative Site | Brownstown | Michigan | 48183 | — |
| Novartis Investigative Site | Dearborn | Michigan | 48126 | — |
| Novartis Investigative Site | Detroit | Michigan | 48202 | — |
| Novartis Investigative Site | West Bloomfield | Michigan | 48322 | — |
| Novartis Investigative Site | Burnsville | Minnesota | 55337 | — |
| Novartis Investigative Site | Coon Rapids | Minnesota | 55433 | — |
| Novartis Investigative Site | Edina | Minnesota | 55435 | — |
| Novartis Investigative Site | Fridley | Minnesota | 55432 | — |
| Novartis Investigative Site | Maplewood | Minnesota | 55109 | — |
| Novartis Investigative Site | Minneapolis | Minnesota | 55404 | — |
| Novartis Investigative Site | Saint Paul | Minnesota | 55102 | — |
| Novartis Investigative Site | Woodbury | Minnesota | 55125 | — |
| Novartis Investigative Site | Columbia | Missouri | 65201 | — |
| Novartis Investigative Site | Jefferson City | Missouri | 65109 | — |
| Novartis Investigative Site | Billings | Montana | 59102 | — |
| Novartis Investigative Site | Henderson | Nevada | 89052 | — |
| Novartis Investigative Site | Henderson | Nevada | 89074 | — |
| Novartis Investigative Site | Las Vegas | Nevada | 89128 | — |
| Novartis Investigative Site | Las Vegas | Nevada | 89148 | — |
| Novartis Investigative Site | Las Vegas | Nevada | 89169 | — |
| Novartis Investigative Site | Cary | North Carolina | 27518 | — |
| Novartis Investigative Site | Elizabeth City | North Carolina | 27909 | — |
| Novartis Investigative Site | Greensboro | North Carolina | 27403 | — |
| Novartis Investigative Site | Raleigh | North Carolina | 27607 | — |
| Novartis Investigative Site | Raleigh | North Carolina | 27614 | — |
| Novartis Investigative Site | Washington | North Carolina | 27889 | — |
| Novartis Investigative Site | Abington | Pennsylvania | 19001 | — |
| Novartis Investigative Site | Philadelphia | Pennsylvania | 19106 | — |
| Novartis Investigative Site | Radnor | Pennsylvania | 19087 | — |
| Novartis Investigative Site | Abilene | Texas | 79606-5208 | — |
| Novartis Investigative Site | Beaumont | Texas | 77701 | — |
| Novartis Investigative Site | Bedford | Texas | 76022 | — |
| Novartis Investigative Site | Dallas | Texas | 75230 | — |
| Novartis Investigative Site | El Paso | Texas | 79902 | — |
| Novartis Investigative Site | El Paso | Texas | 79915 | — |
| Novartis Investigative Site | Fort Worth | Texas | 76104 | — |
| Novartis Investigative Site | Fort Worth | Texas | 76132 | — |
| Novartis Investigative Site | Garland | Texas | 75042 | — |
| Novartis Investigative Site | Grapevine | Texas | 76051 | — |
| Novartis Investigative Site | Houston | Texas | 77024 | — |
| Novartis Investigative Site | Kerrville | Texas | 78028 | — |
| Novartis Investigative Site | Odessa | Texas | 79761 | — |
| Novartis Investigative Site | Plano | Texas | 75075 | — |
| Novartis Investigative Site | Plano | Texas | 75093 | — |
| Novartis Investigative Site | San Antonio | Texas | 78217 | — |
| Novartis Investigative Site | San Antonio | Texas | 78258-3912 | — |
| Novartis Investigative Site | Bountiful | Utah | 84010 | — |
| Novartis Investigative Site | Layton | Utah | 84041 | — |
| Novartis Investigative Site | Murray | Utah | 84157-7000 | — |
| Novartis Investigative Site | Provo | Utah | 84604 | — |
| Novartis Investigative Site | Salt Lake City | Utah | 84102 | — |
| Novartis Investigative Site | Salt Lake City | Utah | 84106 | — |
| Novartis Investigative Site | Sandy City | Utah | 84094 | — |
| Novartis Investigative Site | Arlington | Virginia | 22205 | — |
| Novartis Investigative Site | Chesapeake | Virginia | 23320 | — |
| Novartis Investigative Site | Fairfax | Virginia | 22031 | — |
| Novartis Investigative Site | Gainesville | Virginia | 20155 | — |
| Novartis Investigative Site | Hampton | Virginia | 23666 | — |
| Novartis Investigative Site | Leesburg | Virginia | 20176 | — |
| Novartis Investigative Site | Newport News | Virginia | 23606 | — |
| Novartis Investigative Site | Norfolk | Virginia | 23502 | — |
| Novartis Investigative Site | Virginia Beach | Virginia | 23456 | — |
| Novartis Investigative Site | Williamsburg | Virginia | 23185 | — |
| Novartis Investigative Site | Edmonds | Washington | 98026 | — |
| Novartis Investigative Site | Federal Way | Washington | 98003 | — |
| Novartis Investigative Site | Gig Harbor | Washington | 98332 | — |
| Novartis Investigative Site | Lakewood | Washington | 98499 | — |
| Novartis Investigative Site | Puyallup | Washington | 98372 | — |
| Novartis Investigative Site | Seattle | Washington | 98104 | — |
| Novartis Investigative Site | Seattle | Washington | 98133 | — |
| Novartis Investigative Site | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00968968, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 9, 2019 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00968968 live on ClinicalTrials.gov.